Clinical trial
Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne…
NCT00098358 · Critical Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00098358 |
|---|---|
| Title | Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Proof of Concept Study of Zileuton IR in Patients With Moderate to Severe Facial Acne Vulgaris |
| Lead sponsor | Critical Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acne Vulgaris |
| Intervention type | Drug |
| Interventions | Zileuton |
| Enrollment | 90 |
| Start date | Nov 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Dec 8, 2004 |
| Last update posted | Feb 7, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: